InvestorsHub Logo
Followers 58
Posts 10034
Boards Moderated 1
Alias Born 09/21/2016

Re: falconer66a post# 454339

Monday, 03/18/2024 11:49:29 AM

Monday, March 18, 2024 11:49:29 AM

Post# of 458275

The Anavex 3-71 Schizophrenia Study — Short and Strong

The Anavex 3-71 trial for the treatment of schizophrenia has officially begun. The first patient has entered the trial.

https://www.globenewswire.com/news-release/2024/03/18/2847701/29248/en/Anavex-Life-Sciences-Initiates-Placebo-Controlled-U-S-Phase-2-Clinical-Trial-of-ANAVEX-3-71-in-Schizophrenia.html

This trial will differ in several ways from any of Anavex’s previous human trials, in three significant ways.

Falconer.

Well Done. Thanks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News